PHK
CNST

Point72 Hong Kong’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Point72 Hong Kong’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-790
Closed -$18K – 2523
2021
Q1 		$18K Sell
790
-865
-52% -$26.2K ﹤0.01% 1503
2020
Q4 		$48K Buy
1,655
+1,182
+250% +$29.8K ﹤0.01% 1236
2020
Q3 		$10K Sell
473
-1,340
-74% -$32.7K ﹤0.01% 998
2020
Q2 		$54K Buy
1,813
+1,419
+360% +$51.1K 0.01% 725
2020
Q1 		$12K Buy
+394
New +$13.7K 0.01% 651

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Hong Kong's CNST Position: Q2 2021 in Review

Point72 Hong Kong sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 790 shares — an estimated $18K sold.

Point72 Hong Kong first reported a position in CNST in Q1 2020 and held it in 5 quarters. The position peaked at $54K in Q2 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Point72 Hong Kong reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 790 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $18K.
  • Point72 Hong Kong first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 5 quarters.
  • Point72 Hong Kong's Constellation Pharmaceuticals, Inc. position peaked at $54K in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.